Samsung Biologics
207940.KS
#395
Rank
A$81.37 B
Marketcap
$1,133
Share price
-0.94%
Change (1 day)
19.60%
Change (1 year)

Earnings for Samsung Biologics (207940.KS)

Earnings in 2024 (TTM): A$1.56 Billion

According to Samsung Biologics 's latest financial reports the company's current earnings are A$3.30 Billion. , an increase over its 2023 earnings that were of A$1.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Samsung Biologics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 A$1.63 B12.65%
2023 A$1.44 B9.77%
2022 A$1.31 B67.66%
2021 A$0.78 B103.97%
2020 A$0.38 B57.39%
2019 A$0.24 B-45.46%
2018 A$0.44 B-390%
2017 -A$0.16 Billion-46.74%
2016 -A$0.3 Billion